Closing Bell: ASX claws higher from 200-day low to close just above neutral

The ASX staged an info-tech fuelled recovery in the final hour, clawing back to neutral levels as losses in banking stocks weighed heavy.

Resources Top 5: Five-year Plutonic stoush ends with $48m win for Zuleika Gold

Zuleika scores $48m in its Plutonic dispute, MBK reports high-grade gold hits, and 3D Energi strikes gas in both Essington-1 zones.

True Width: Lincoln Liu on rebuilding US antimony play Red Mountain Mining from the ground up

Red Mountain Mining had to be rebuilt from the ground up, and MD Lincoln Liu says a US critical minerals push is paying off.

Why AI’s big short is not done yet

As trillion-dollar AI capex plans collide with doubts about returns and capacity, even the optimists are warning of ‘ugly days and weeks’ ahead.

Race Oncology targets two new cancer markets with RC220’s unique molecular action

Race Oncology has identified major new opportunities in two new cancer indications for its RC220 therapy after identifying its unique mechanism of action.

StockTake: Critical Locksley-Columbia deal sets centre stage on US rare earths push

Tylah Tully looks into Locksley Resources and a research agreement with Columbia University to advance next-generation US processing technology for rare earths.